Gamma-Aminobutyric Acid

Gamma-Aminobutyric Acid

SCHEMBL10364387

Cc1ccc(S(=O)(=O)O)cc1.NCCCC(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Gamma-Aminobutyric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.48
LMNA P02545 3/20 0.48
CYP1A2 P05177 2/20 0.48
THRB P10828 2/20 0.48
BLM P54132 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
GABRR3 A8MPY1 1/20 0.48
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
HDAC3 O15379 1/20 0.48
GABBR2 O75899 1/20 0.48
GABRA1 P14867 1/20 0.48
TSHR P16473 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRR1 P24046 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRR2 P28476 1/20 0.48
SLC6A1 P30531 1/20 0.48
GABRA5 P31644 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta-Alanine SCHEMBL18230715 0.90 CYP2D6 (0.49) KMT2ALMNACYP1A2TSHRCYP2C9
Adipic Acid SCHEMBL5313716 0.90 ALDH1A1 (0.50) KMT2ALMNACYP2C9ALDH1A1MAPK1
Glutarate SCHEMBL31490757 0.90 KMT2A (0.49) KMT2ALMNATSHRCYP2C9ALDH1A1
Putrescine SCHEMBL10842435 0.86 CYP2C9 (0.49) KMT2ALMNACYP1A2TSHRCYP2C9
SCHEMBL11546476 0.86 CYP2C9 (0.49) KMT2ALMNACYP1A2TSHRCYP2C9
Valeric Acid SCHEMBL27767030 0.85 ALDH1A1 (0.48) KMT2ALMNATSHRHDAC11CYP2C9
SCHEMBL8981419 0.84 CYP2C9 (0.48) KMT2ALMNACYP1A2TSHRCYP2C9
Succinic Acid SCHEMBL11462893 0.84 KMT2A (0.53) KMT2ALMNACYP1A2TSHRCYP2C9
Succinic Acid SCHEMBL27928188 0.84 KMT2A (0.53) KMT2ALMNACYP1A2TSHRCYP2C9
Glycine SCHEMBL5685912 0.84 CYP2C9 (0.51) LMNACYP1A2TSHRCYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110105389-A The methoxy acrylic ester compounds and synthetic method of one kind cation containing triphenyl phosphonium and application 中国农业大学 2019-08-09 CN disclosed
EP-0147211-B1 4H-3,1-BENZOXAZIN-4-ONES AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION SYNTEX (U.S.A.) INC. (US) 1990-09-12 EP disclosed
US-4657893-A ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) INC. (US) 1987-04-14 US disclosed
EP-0147211-A2 4H-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation SYNTEX (U.S.A.) INC. (US) 1985-07-03 EP disclosed